2018
DOI: 10.1002/ange.201811289
|View full text |Cite
|
Sign up to set email alerts
|

Attrition‐Enhanced Deracemization of the Antimalaria Drug Mefloquine

Abstract: Mefloquine is an important drug for prevention and treatment of malaria. It is commercially available as a racemic mixture, wherein only one enantiomer is active against malaria, while the other one causes severe psychotropic effects. By converting the drug into a compound that crystallizes as a racemizable racemic conglomerate, the deracemization of mefloquine into the desired enantiomer was achieved.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…Mefloquine is sold as a racemate of erythro ( anti ) isomer; however, there exist a number of reported asymmetric syntheses 3 and procedures for the separation 4 or conversion of enantiomers. 5 The dextrorotary compound was proven to be more effective against Plasmodium than its levorotary antipode. The latter is also much more toxic and prone to induce psychotic behavior.…”
Section: Introductionmentioning
confidence: 99%
“…Mefloquine is sold as a racemate of erythro ( anti ) isomer; however, there exist a number of reported asymmetric syntheses 3 and procedures for the separation 4 or conversion of enantiomers. 5 The dextrorotary compound was proven to be more effective against Plasmodium than its levorotary antipode. The latter is also much more toxic and prone to induce psychotic behavior.…”
Section: Introductionmentioning
confidence: 99%